Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Venlafaxine ER in Pediatric Social Anxiety Disorder
NCT00238719Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 1999
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of venlafaxine in Social Anxiety Disorder (SAD), sponsored by Pfizer. Started Dec 1999; status: completed.
02
Drugs
venlafaxine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT00238719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00238719.